Publications by authors named "A Byszek"
Article Synopsis
- The POL-MOL study aimed to assess the use of molecular testing in Polish patients diagnosed with metastatic non-small cell lung cancer (NSCLC), as its extent was previously unknown.
- Oncologists completed questionnaires about molecular testing for various genetic mutations and PD-L1 assessment, collecting data from 1001 patients receiving systemic treatment.
- Results indicated that molecular tests were conducted in 78% of NSCLC patients, with higher testing rates in more advanced disease stages, and about 30% of tests in squamous cell carcinoma patients were positive for specific mutations.
Background And Objective: Epidermal growth factor receptor (EGFR) inhibitors are not equally effective in all cancer patients. One potential clinical factor that could help in selecting patients who may benefit from treatment with cetuximab is acneiform rash, which correlates with the clinical response to EGFR inhibitors. Some previous studies have suggested that the tendency to develop rash may depend on polymorphisms in the EGFR gene.
View Article and Find Full Text PDFBackground: Despite the findings of several randomized clinical studies, the role of gentamicin collagen implant (GCI) in rectal cancer surgery is unclear. Local pelvic application of GCI following preoperative radiotherapy and total mesorectal excision (TME) was evaluated to determine the risk of surgical site infections (SSI).
Methods: In this single-center trial, 176 patients with rectal cancer after preoperative, short-term radiotherapy (5 × 5 Gy) were randomized either to the study group in which GCI was used or in the control group without GCI.